(Q2)Sep 30, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 7.40%-554.09K | 68.78%721.3K | 57.42%-598.38K | -35.04%1.01M | 146.46%149.59K | -431.79K | 363.94%427.37K | -1,203.81%-1.41M | 1,583.12%1.56M | -335.03%-321.95K |
Net income from continuing operations | 69.64%-130.53K | -137.24%-42.85K | -535.93%-429.89K | -30.00%-126.69K | 116.64%171.27K | --55.04K | 156.90%115.07K | 139.67%98.61K | 46.16%-97.45K | -54.08%-1.03M |
Operating gains losses | -170.00%-7.05K | --1.55K | --10.07K | --3.36K | 911.82%45.69K | --5.37K | ---- | ---- | ---- | 103.42%4.52K |
Depreciation and amortization | -8.93%22.69K | -13.33%20.89K | 3.39%24.92K | 3.40%24.92K | 34.14%96.4K | --24.1K | 0.71%24.1K | 23.46%24.1K | 458.36%24.1K | 22.64%71.87K |
Asset impairment expenditure | --0 | ---- | --41.35K | ---- | --0 | ---- | ---- | ---- | ---- | 56.78%15.34K |
Remuneration paid in stock | -57.96%14.13K | -67.30%22.24K | -1.18%33.6K | -23.88%51K | -19.38%262K | --93K | 47.83%68K | -68.81%34K | -27.96%67K | 8.79%325K |
Other non cashItems | 25.77%21.35K | -51.71%23.09K | 254.78%16.98K | -15.19%14.14K | 236.52%103.24K | --33.97K | 444.77%47.81K | --4.79K | --16.67K | 277.72%30.68K |
Change In working capital | -60.68%-474.68K | 427.29%696.4K | 81.14%-295.42K | -32.46%1.05M | -303.52%-529.01K | ---643.27K | 445.74%132.07K | -780.19%-1.57M | 778.45%1.55M | -30.90%259.93K |
-Change in receivables | 93.53%-14.6K | -119.54%-156.89K | 30.76%-225.74K | -3,168.03%-251.52K | 23.81%-245.96K | ---731.12K | 851.41%802.97K | -12,599.92%-326.01K | 203.65%8.2K | -267.79%-322.84K |
-Change in inventory | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
-Change in prepaid assets | 618.68%1.26M | -107.36%-88.34K | 83.84%-242.65K | 426.30%457.66K | -263.57%-391.5K | --49.81K | 9,442.90%1.2M | -2,527.16%-1.5M | -196.60%-140.26K | 291.27%239.34K |
-Change in payables and accrued expense | -134.11%-72.23K | 410.06%94.36K | 87.85%211.73K | 947.13%100.61K | -69.12%108.45K | --38.05K | -146.76%-30.43K | -29.34%112.71K | -128.58%-11.88K | 17.62%351.24K |
-Change in other working capital | -4,147.23%-1.65M | --847.26K | -126.14%-38.76K | -56.32%739.35K | ---- | ---- | ---- | 1,187.49%148.32K | 67,516.53%1.69M | -176.05%-7.81K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 7.40%-554.09K | 68.78%721.3K | 57.42%-598.38K | -35.04%1.01M | 146.46%149.59K | ---431.79K | 364.24%427.37K | -1,203.81%-1.41M | 1,583.12%1.56M | -335.03%-321.95K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 98.35%-912 | 84.53%-18.06K | 32.72%-55.16K | -17.05%-126.84K | -145.15%-416.47K | -109.35K | -46.49%-116.76K | -81.99K | -108.37K | -114.16%-169.88K |
Net PPE purchase and sale | ---- | ---- | ---- | ---- | -1,468.70%-46.97K | ---- | ---- | ---- | ---- | 96.23%-2.99K |
Net business purchase and sale | ---- | ---- | ---- | -17.05%-126.84K | -121.41%-369.5K | ---- | ---- | ---81.99K | ---108.37K | ---166.89K |
Net other investing changes | 98.35%-912 | ---- | ---55.16K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 98.35%-912 | 84.53%-18.06K | 32.72%-55.16K | -17.05%-126.84K | -145.15%-416.47K | ---109.35K | -46.49%-116.76K | ---81.99K | ---108.37K | -114.16%-169.88K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 536.76%67.54K | -135.85%-226.47K | -102.82%-15.46K | -498.70%-461.17K | -22.35%410.53K | -886.03K | 132.12%631.67K | 5,055.56%549.23K | 1,138.14%115.67K | 7,831.18%528.66K |
Net issuance payments of debt | 551.44%67.54K | -129.82%-192.95K | -102.72%-14.96K | -5,058.84%-461.17K | -34.92%305.49K | ---900.12K | 204.51%647.08K | 2,996.45%549.23K | 385.01%9.3K | 1,374.25%469.41K |
Net common stock issuance | ---- | --0 | ---- | --0 | --102.54K | ---1.33K | -104.17%-2.5K | --2.5K | --103.87K | --0 |
Cash dividends paid | --0 | ---- | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | -95.78%2.5K | --0 | ---- | ---- | --2.5K | --59.25K |
Interest paid (cash flow from financing activities) | --0 | ---- | ---503 | ---- | --0 | --15.42K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 536.76%67.54K | -135.85%-226.47K | -102.82%-15.46K | -498.70%-461.17K | -22.35%410.53K | ---886.03K | 132.12%631.67K | 5,055.56%549.23K | 1,138.14%115.67K | 7,831.18%528.66K |
Net cash flow | ||||||||||
Beginning cash position | -28.45%489.59K | -97.84%15.25K | -58.26%684.25K | 186.60%220.63K | 127.51%76.98K | --1.65M | 659.43%705.53K | 1,290.96%1.64M | 127.51%76.98K | -83.44%33.84K |
Current changes in cash | 27.14%-487.47K | -49.40%476.77K | 28.68%-669.01K | -72.88%424.82K | 290.01%143.65K | ---1.43M | 2,989.24%942.28K | -6,888.29%-937.97K | 1,822.20%1.57M | 123.00%36.83K |
Effect of exchange rate changes | ---- | ---- | ---- | 996.37%38.8K | ---- | ---- | ---- | ---- | -272.40%-4.33K | 161.49%6.31K |
End cash Position | -86.09%2.12K | -70.14%492.01K | -97.84%15.25K | -58.26%684.25K | 186.60%220.63K | --220.63K | 1,144.46%1.65M | 659.43%705.53K | 1,290.96%1.64M | 127.51%76.98K |
Free cash from | 7.40%-554.09K | 68.78%721.3K | 57.42%-598.38K | -35.04%1.01M | 131.58%102.62K | ---478.76K | 364.24%427.37K | -413.96%-1.41M | 1,583.12%1.56M | -111.92%-324.94K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data